Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
163 Results for "
enterococcus
" in MedChemExpress (MCE) Product Catalog:
Products (163)
163 Results for "enterococcus" in MCE Product Catalog:
Cat. No.: HY-N19903
CAS No.: 2243140-21-6
Category:
Target:
Cat. No.: HY-187554
CAS No.: 1091682-50-6
Target:
Research Areas:
IDP-73152 is an orally active bacterial Peptide deformylase inhibitor and Antibiotic. IDP-73152 exhibits activity against Gram-positive bacteria. IDP-73152 can be used in the research of infections caused by Streptococcus pneumoniae, Enterococcus faecium and Staphylococcus aureus .
Cat. No.: HY-187554A
CAS No.: 1936442-71-5
Target:
Research Areas:
IDP-73152 mesylate is an orally active bacterial Peptide deformylase inhibitor and Antibiotic. IDP-73152 mesylate exhibits activity against Gram-positive bacteria. IDP-73152 mesylate can be used in the research of infections caused by Streptococcus pneumoniae, Enterococcus faecium and Staphylococcus aureus .
Cat. No.: HY-184417
CAS No.: 3085883-97-9
Energy-coupling factor-IN-1 is an energy-coupling factor (ECF) transporter inhibitor with an IC50 of 42.84 μM against ECF-FolT2. Energy-coupling factor-IN-1 binds to the interface between the S component and the ECF module, and inhibits the uptake of folic acid and pantothenic acid via the target transporter. Energy-coupling factor-IN-1 acts as a bactericidal agent, exerting rapid and sustained activity for 24 h against Enterococcus faecium, while also acting against Gram-positive bacteria including drug-resistant strains. Energy-coupling factor-IN-1 improves the survival rate of zebrafish embryos infected with Enterococcus faecium. Energy-coupling factor-IN-1 can be used in studies of Gram-positive bacterial infections .
Cat. No.: HY-W541015
CAS No.: 89-48-5
Target:
Cat. No.: HY-181686
Research Areas:
Antibacterial agent 326 is a bactericide that inhibits the growth of various bacterial strains. Antibacterial agent 326 inhibits biofilm formation in Escherichia coli, disrupts bacterial cell membranes, induces oxidative stress and lipid peroxidation in Escherichia coli, increases ROS levels, and reduces GSH activity. Antibacterial agent 326 can be used in studies of bacterial infections, including those caused by Escherichia coli, Staphylococcus aureus, Enterococcus faecalis, Listeria spp., Bacillus subtilis, Serratia marcescens, Salmonella enteritidis and Acinetobacter calcoaceticus .
Cat. No.: HY-184679
CAS No.: 890179-59-6
Target:
Research Areas:
MCZ-038 is a thiourea antibiotic with bactericidal activity. MCZ-038 exerts its effects by interfering with the lipid organization or fluidity of bacterial cell membranes . MCZ-038 can be used in studies related to drug-resistant Staphylococcus aureus infections and Vancomycin (HY-B0671)-resistant Enterococcus faecium infections .
Cat. No.: HY-N22017
CAS No.: 2341324-20-5
Category:
Target:
Cat. No.: HY-184387
CAS No.: 2552327-34-9
Pleuromutilin conjugate T7 is a broad-spectrum antibacterial agent. Pleuromutilin conjugate T7 inhibits bacterial energy uptake, reverses drug efflux, interferes with carbohydrate metabolism, inhibits protein synthesis, disrupts biofilms, impairs cell membrane integrity, and attenuates the functions of virulence and adhesion factors. Pleuromutilin conjugate T7 can be used in studies related to Methicillin (HY-121544)-resistant Staphylococcus aureus (MRSA) infections, multidrug-resistant Enterococcus faecalis infections, and Gram-negative bacterial infections .
Cat. No.: HY-N19135
CAS No.: 163768-82-9
Category:
Target:
Cat. No.: HY-184287
Target:
Research Areas:
Antibacterial agent 352 is an orally active Antibacterial agent. Antibacterial agent 352 binds to the active cavity of Staphylococcus aureus DNA gyrase via hydrogen bonding, π-π stacking and hydrophobic interactions, thereby blocking bacterial DNA synthesis. Antibacterial agent 352 exhibits antibacterial activity against Gram-positive bacteria including Staphylococcus aureus, Bacillus pumilus, Staphylococcus epidermidis and Enterococcus faecalis. Antibacterial agent 352 can disrupt established Staphylococcus aureus biofilms and inhibit the formation of Staphylococcus aureus biofilms. Antibacterial agent 352 can be used in the research of Staphylococcus aureus wound infections .
Cat. No.: HY-W039699
CAS No.: 938-94-3
Synonyms: 2-(4-Methylphenyl)propionic acid
Target:
Research Areas:
2-(p-Tolyl) propanoic acid (2-(4-methylphenyl) propionic acid) acts as an Antimicrobial agent intermediate. 2-(p-Tolyl) propanoic acid inhibits COX-1 and COX-2 enzymes, with IC50 values of 38.23 μM and 64.30 μM, respectively. 2-(p-Tolyl) propanoic acid is applicable to research on E. coli, Enterococcus faecalis, Listeria monocytogenes, and Staphylococcus aureus .
Cat. No.: HY-N19214
CAS No.: 3040055-91-9
Category:
Target:
Cat. No.: HY-N14119
CAS No.: 105650-12-2
Category:
Target:
Cat. No.: HY-137527
CAS No.: 24570-39-6
Cat. No.: HY-N5196
CAS No.: 214044-52-7
Synonyms: Nocathiacine I
Category:
Target:
Cat. No.: HY-182798
Research Areas:
Antibacterial agent 337 is an antibacterial agent. Antibacterial agent 337 specifically interacts with PG in bacterial cell membranes, triggering membrane disruption, membrane depolarization, increased permeability, cytoplasmic leakage, ROS accumulation and rapid bacterial death. Antibacterial agent 337 inhibits biofilm formation and disrupts mature biofilms. Antibacterial agent 337 exhibits potent in vivo antibacterial efficacy in a mouse model of Staphylococcus aureus skin abscess. Antibacterial agent 337 can be used in studies of Gram-positive bacterial infections, including methicillin-resistant Staphylococcus aureus infections, vancomycin-resistant Enterococcus faecalis infections and bacterial biofilm infections .
Cat. No.: HY-112027
CAS No.: 105394-83-0
Synonyms: Ciprofloxacin impurity E
Decarboxy ciprofloxacin (Decarboxylated ciprofloxacin) is an antibacterial agent. Decarboxy ciprofloxacin displays antibacterial activities against Staphylococcus aureus, Staphylococcus epidermidis, Enterococcus faecalis, Bacillus subtilis, Enterobacter cloacae, Serratia marcescens and especially potent activity against Escherichia coli .
Cat. No.: HY-N14172
CAS No.: 69176-72-3
Category:
Cat. No.: HY-N12229
CAS No.: 1821668-16-9
Category:
Target:
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
